Aurora Financial JournalApotea AB (publ) (APOTEA.ST)
Nasdaq Stockholm · Financial statements, TTM figures and earnings dates
In fiscal year 2024 (ended December 31, 2024), Apotea AB (publ) reported revenue of SEK 6.54B and net income of SEK 214.9M. Annual financial statements are available for fiscal years 2023 to 2024, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| SEK | FY2024 2024-12-31 | FY2023 2023-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | SEK 6.54B | SEK 5.45B |
| Operating income | SEK 265.8M | SEK 113.6M |
| Net income | SEK 214.9M | SEK 87.0M |
| Diluted EPS | SEK 2.09 | SEK 0.85 |
| Cash flow | ||
| Operating cash flow | SEK 206.2M | SEK 215.8M |
| Capital expenditure | SEK 162.8M | SEK 119.9M |
| Free cash flow | SEK 43.4M | SEK 95.9M |
| Balance sheet | ||
| Cash and equivalents | SEK 27.3M | SEK 19.1M |
| Total assets | SEK 1.63B | SEK 1.34B |
| Total liabilities | SEK 991.7M | SEK 911.4M |
| Total debt | SEK 79.6M | SEK 66.9M |
| Shareholders' equity | SEK 615.2M | SEK 403.7M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full APOTEA.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open APOTEA.ST financials →